PRTN3 and rheumatoid arthritis: Reports indicate that approximately 60% of patients with early RA and approximately 80% of patients with confirmed RA are positive for ACPA in peripheral serum and that an abnormal increase in pathogenic ACPA plays a critical role in the development of RA pain and immune maintenance (123, 124).